Literature DB >> 18475629

Effects of triazolodiazepine on the production of interleukin-6 from murine spleen cells and rabbit synovial cells in vitro.

D W Ju1, Q Y Zheng, X T Cao, Q H Zheng, X J Guan, H B Wang.   

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine that regulates the immune response, acute phase anaphylactic reaction, and haematopoiesis. Lipopolysaccharide (6-24 mug/ml) significantly induced IL-6 release from murine spleen cells. In cultured rabbit synovial cells interleukin-1 (IL-1, 1-10 U/ml) induced IL-6 production in a concentration-dependent manner. Triazolodiazepine (Tri) is a hetrazepine platelet-activating factor antagonist. In this study we found that Tri (0.1-10 mumol/l) exerted strong inhibitory effects on LPS stimulated IL-6 production in murine spleen cells. Kinetic studies showed that the inhibition of IL-6 release was time-independent. In rabbit synovial cells Tri also reduced IL-6 release induced by IL-1 and tumour necrosis factor. Inhibition of cytokine production by Tri may partially explain its wide and strong anti-inflammatory effects.

Entities:  

Year:  1995        PMID: 18475629      PMCID: PMC2365624          DOI: 10.1155/S0962935195000226

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  13 in total

Review 1.  Interleukin-6 and its relation to inflammation and disease.

Authors:  T Hirano
Journal:  Clin Immunol Immunopathol       Date:  1992-01

2.  Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.

Authors:  T Hirano; T Matsuda; M Turner; N Miyasaka; G Buchan; B Tang; K Sato; M Shimizu; R Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 3.  Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

4.  Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation.

Authors:  P Theisen-Popp; H Pape; R Müller-Peddinghaus
Journal:  Int J Immunopharmacol       Date:  1992-05

5.  Platelet-activating factor enhances interleukin-6 production by alveolar macrophages.

Authors:  M Thivierge; M Rola-Pleszczynski
Journal:  J Allergy Clin Immunol       Date:  1992-11       Impact factor: 10.793

6.  Leflunomide inhibits cytokine-induced DNA synthesis of rabbit synovial cells in culture.

Authors:  D W Ju; Q Y Zheng; H B Wang; J Fang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1994-05

7.  The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model.

Authors:  I Engelberts; E J von Asmuth; C J van der Linden; W A Buurman
Journal:  Lymphokine Cytokine Res       Date:  1991-04

8.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

9.  Inhibitory effects of triazolodiazepine on mouse splenocytes and peritoneal macrophages in vitro.

Authors:  D W Ju; Q Y Zheng; H B Wang; J Fang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1994-01

10.  Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages.

Authors:  D W Ju; Q Y Zheng; H B Wang; X F Wang; J Fang
Journal:  Yao Xue Xue Bao       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.